Edition:
United Kingdom

Alder Biopharmaceuticals Inc (ALDR.OQ)

ALDR.OQ on NASDAQ Stock Exchange Global Market

12.82USD
7:57pm GMT
Change (% chg)

$0.46 (+3.72%)
Prev Close
$12.36
Open
$12.38
Day's High
$12.98
Day's Low
$12.30
Volume
206,193
Avg. Vol
256,314
52-wk High
$20.85
52-wk Low
$9.51

Chart for

About

Alder BioPharmaceuticals, Inc., is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize genetically engineered therapeutic antibodies with the potential to meaningfully transform current treatment paradigms. Alder's lead pivotal-stage product candidate, eptinezumab, is being evaluated... (more)

Overall

Beta: 2.62
Market Cap(Mil.): $863.35
Shares Outstanding(Mil.): 67.71
Dividend: --
Yield (%): --

Financials

  ALDR.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -5.14 -- --
ROI: -76.39 8.99 14.48
ROE: -76.45 10.13 15.99

Earnings vs. Estimates